Product Information
OLMESARTAN MEDOXOMIL 5 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0551 per EA under NDC 68462043690. Its NADAC has been published 188 times since Jan 18, 2023.
FDA first approved this application on May 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462043690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA203281FDA Approved
5/25/2017
TE Code
AB
On Market Since
5/25/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has been published 188 times since Jan 18, 2023, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0551 per EA |
|---|---|
| All-time high | $0.0844 (Sep 11, 2024) |
| All-time low | $0.0551 (Aug 19, 2026) |
| 52-week high | $0.0610 |
| 52-week low | $0.0551 |
| Median price | $0.0627 |
| Average price | $0.0637 |
| Largest weekly change | -24.8% (Nov 20, 2024) |
| Weeks tracked | 188 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 5 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0551 per EA (NDC 68462043690), effective Aug 19, 2026.
How has the price of OLMESARTAN MEDOXOMIL 5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has declined 10.6%. It has been tracked across 188 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 5 MG TAB?
Since Jan 18, 2023, the NADAC for OLMESARTAN MEDOXOMIL 5 MG TAB has ranged from a low of $0.0551 (Aug 19, 2026) to a high of $0.0844 (Sep 11, 2024), with a median of $0.0627 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 5 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN MEDOXOMIL 5 MG TAB?
OLMESARTAN MEDOXOMIL 5 MG TAB (NDC 68462043690) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.